Antiretroviral therapy in Russia
- Authors: Yurin O.G.1, Ladnaia N.N.1, Kravchenko A.V.1, Sokolova E.V.1, Suvorova Z.K.1, Narsiya R.S.1, Pokrovsky V.V.1
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Issue: Vol 11, No 3 (2021)
- Pages: 46-52
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287779
- DOI: https://doi.org/10.18565/epidem.2021.11.3.46-52
- ID: 287779
Cite item
Abstract
Full Text
About the authors
Oleg G. Yurin
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: oleg_gerald@mail.ru
MD, Leading Researcher
Natalia N. Ladnaia
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: nladnaia@hotmail.com
Cand. Biol. Sci., Senior Researcher
Alexey V. Kravchenko
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: alexey-kravtchenko@yandex.ru
MD, Leading Researcher
Ekaterina V. Sokolova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ekaterinasokolova007@rambler.ru
Cand. Med. Sci., Researcher
Zoya K. Suvorova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: zksu@inbox.ru
Cand. Biol. Sci., Senior Researcher
Roza S. Narsiya
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: rnarsiya@mail.ru
Deputy Manager
Vadim V. Pokrovsky
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: pokrovsky.vad@yandex.ru
MD, Academician of the Russian Academy of Sciences, Head, Department of Epidemiology and Prevention of AIDS
References
- Severe P., Juste M.A., Ambroise A. Eliacin L., Marchand C., Appolon S. et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N. Engl. J. Med. 2010; 363(3): 257-265.
- Newman C.E., de Wit J., Persson A., Holt M., Slavin S., Kidd M.R. et al. Understanding Concerns About Treatmentas-Prevention Among People with HIV who are not Using Antiretroviral Therapy. AIDS Behav 2015; 19(5): 821-831. PMID: 25432878 doi: 10.1007/s10461-014-0959-9
- Ending AIDS Progress towards the 90-90-90 targets. Global AIDS updates 2017, 196 p. http://ecuo.org/mvdev/wp-content/ uploads/sites/4/2017/07/Global_AIDS_update_2017_en-1. pdf
- Global AIDS monitoring 2017: indicators for monitoring the 2016 United Nations Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2017. http://www.unaids.org/sites/default/files/media_asset/2017-Global-AIDS-Monitoring_en.pdf
- Покровский В.И., Краевский А.А., Покровский В.В., Юрин О.Г., Урываев Л.В., Галегов Г.А. и др. Об основных результатах исследований по направлению «СПИД». Вопросы вирусологии 1995; 409(1): 2-4.
- Покровский В.И., Решетникова Л.Н., Урываев Л.В., Покровский В.В., Юрин О.Г., Галегов Г.А. и др. О программе научных исследований по проблеме СПИД. ЖМЭИ 1995; (4): 2-5
- Yurin O., Kravchenko A., Golochvastova E., Kraevskiy A, Serebrovskai L, Pokrovskiy V. et al. The first results of the phase 1 study of «Phosphazid», the new antiretroviral drug. Sixth European Conference on Clinical Aspects and Treatment of HIV Infection. Abstract Book. Hamburg, Germany, 1997; 333
- Юрин О.Г., Кравченко А.В., Голохвастова Е.Л., Краевский А.А., Серебровская Л.В., Покровский В.В. и др. Первая фаза клинических испытаний Никавира. Материалы научно-практической конференции «Актуальные вопросы ВИЧ-инфекции». СПб, 1997; 154-155
- Yurin O., Kravchenko A., Serebrovskaya L., Golochvastova E., Kraevskiy A., Serebrovskaiy L. et al. The Phase 1of the trial of «Phosphazid». The New Reverse Transcriptaze Inhibitor. AIDS 1998; 12( Supl. 4): 240.
- Покровский В.В., ред. ВИЧ-инфекция и СПИД. Национальное руководство. М.: ГЭОТАР- Медиа, 2013. 608 с.
- Hoffmann C., Rocktron J.K. HIV 2015/2016. Medicin focus verlag. Hamburg: Medicin focus verlag, 2015. 756 p. http://www.hibook.com
- Кравченко А.В., Юрин О.Г. Антиретровирусная терапия. Часть 1. Показания к назначению. В кн.: Покровский В.В., ред. Избранные лекции по ВИЧ-инфекции. М.: ГЭОТАР-Медиа, 2015: 265-290.
- Ефремова О.С., Юрин О.Г. Сравнительная характеристика основных международных и национальных рекомен даций по лечению хронического гепатита С. Эпидемиол. инфекц. болезни. Актуал. вопр. 2016; (3); 27-34
- NSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N. Engl. J. Med. 2015; 379(9): 795-807
- Guidelines for the use of antiretroviral agents in HIV 1-infected adults and adolescents. Developed by the panel on clinical practices for treatment of HIV infection convened by the Department of Health and Human Services (DHHS). November 4, 2016. http://www.AIDSinfo.nih.gov/guidelines
- Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Second ed. WHO, June 2016. 480 р. http://www.who.int/hiv
- Transition to new antiretroviral drags in HIV programes: Clinical and programatic consideration. WHO, July 2017. 34 p. http://www.who.int/hiv
- EACS Guidelines Version 8.1. October 2016. 297 p. http://www.eacsociety
- Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г. и др. Национальные рекомендации по диспансерному наблю -дению и лечению больных ВИЧ-инфекцией (клинический протокол). Эпидемиол. инфекц. болезни. Актуал. вопр. 2017; (6, приложение). 87 с.
- Cohen M.S., Chen Y.O., McCanly M., Gamble T., Hossienipour M., Kumrasamy N. et al. Prevention of HIV-1 infection witu early antiretroviral therapy. N. Engl. J. Med. 2011; 365(6): 493-505
- Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Буравцова Е.В. и др. Рекомендации по лечению ВИЧ-инфекции и связанных с ней заболеваний, химиопрофилактике заражения ВИЧ. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; (4, приложение). 96 с